Boosters for adults aged 18-29 - expected harms are not outweighed by public health benefits given the modest and transient effectiveness of vaccines against transmission
Kevin Bardosh
University of Washington; University of Edinburgh - Edinburgh Medical School
Allison Krug
Artemis Biomedical Communications LLC
Euzebiusz Jamrozik
University of Oxford
Trudo Lemmens
University of Toronto - Faculty of Law
Salmaan Keshavjee
Harvard University - Harvard Medical School
Vinay Prasad
University of California, San Francisco (UCSF)
Martin A. Makary
Johns Hopkins University - Department of Surgery
Stefan Baral
John Hopkins University
Tracy Beth Høeg
Florida Department of Health; Sierra Nevada Memorial Hospital
|
No comments:
Post a Comment